- $1.58bn
- $1.25bn
- $593.82m
Brief: FinnGen Selects Azenta To Propel Personalized Medicine For Population Health Study
Brief: Azenta To Collaborate With Crohn's & Colitis Foundation To Support Clinical Research
Azenta Inc expected to post earnings of 2 cents a share - Earnings Preview
Analysis: Nvidia's dizzying rally spurs rush into AI-themed ETFs
U.S. RESEARCH ROUNDUP-Idexx Laboratories, Fleetcor Technologies,Huntington Ingalls Industries
Azenta Inc reports results for the quarter ended in December - Earnings Summary
Azenta Inc expected to post a loss of 3 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Atlassian, Humana, Veradigm
Brief: Azenta Says Co's Board Size Will Be Reduced To Nine Members
Azenta surges on upbeat Q4 results, board rejig announcement
Azenta makes board changes, takes other steps; avoids proxy fight with activist
Activist investor Politan Capital nominates candidates to Azenta's board (updated)
Activist investor Politan Capital nominates candidates to Azenta's board
Azenta edges higher as activist investor Politan boosts stake
Activist investor Politan Capital increases ownership in Azenta -filing
U.S. RESEARCH ROUNDUP-Celanese, Draftkings, Sovos Brands
Azenta Inc reports results for the quarter ended in June - Earnings Summary
Azenta Inc expected to post a loss of 2 cents a share - Earnings Preview
Mexico's rulers scoop up opposition bastion ahead of presidency race (updated)